HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study.

AbstractPURPOSE:
Inverse treatment planning and intensity-modulated radiation therapy (IMRT) promise advantages in the treatment of tumors of the head and neck region. Currently published studies use IMRT only in the treatment of the primary tumor. In these studies, the lymph nodes of the neck were treated using conventional techniques. The feasibility of an IMRT technique which allows treatment of the complete target volume, including the primary tumor and lymph nodes, without a beam split is described.
PATIENT AND METHOD:
For inverse treatment planning, the KonRad planning system was used. The primary as well as the secondary PTV (bilateral lymph node levels) were treated with one intensity-modulated primary plan. To increase the dose in the primary PTV and suspicious lymph nodes, an intensity-modulated boost plan was performed. The "step and shoot" IMRT technique was used. A plan comparison between the described IMRT approach and an IMRT approach using a split-beam technique was performed focusing on the treatment time. A patient with a carcinoma of the nasopharynx was treated with curative intent by a combined radiochemotherapy.
RESULTS:
The median total dose to the primary PTV was 70 Gy, to suspicious lymph nodes > or = 66.0 Gy, and to the secondary PTV 52 Gy. The defined maximum doses to the organs at risk were not exceeded, and the median dose to the protected parotid gland amounted to 21 Gy. Comparison of the treatment time between both IMRT approaches revealed only a slightly shorter treatment time (1-3 min) for the split-beam IMRT technique without considering the remaining conventional treatment parts of the split-beam IMRT technique. The patient achieved a complete response, and 18 months after treatment no signs of recurrent disease are visible.
CONCLUSIONS:
IMRT allows the treatment of the target volumes with high doses combined with an excellent sparing of the organs at risk. The IMRT approach presented here makes the treatment of the whole target volume with a single-beam arrangement feasible and does not increase the treatment time compared to a split-beam IMRT technique. Treatment time was comparable to a conventional three-field technique combined with electrons. This IMRT technique can prevent over- or underdosage at field matchlines in the head and neck region and, moreover, is able to spare parotid glands and therefore better avoid xerostomia compared to conventional techniques.
AuthorsMarc W Münter, Jürgen Debus, Holger Hof, Simeon Nill, Peter Häring, Thomas Bortfeld, Michael Wannenmacher
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 178 Issue 9 Pg. 517-23 (Sep 2002) ISSN: 0179-7158 [Print] Germany
PMID12426839 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Cisplatin
  • Fluorouracil
Topics
  • Algorithms
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Fluorouracil (administration & dosage)
  • Follow-Up Studies
  • Humans
  • Lymph Nodes (radiation effects)
  • Lymphatic Metastasis (radiotherapy)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms (diagnosis, drug therapy, radiotherapy)
  • Particle Accelerators
  • Phantoms, Imaging
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Software
  • Stereotaxic Techniques
  • Time Factors
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: